Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6017

Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results

$
0
0
🤝 Lilly's Zepbound plus Taltz combo: The company said the drugs, when taken together, helped 27.1% of patients with plaque psoriasis and obesity (or who were overweight) achieve full skin clearance ...

Viewing all articles
Browse latest Browse all 6017

Trending Articles